The introduction of the 750mcg teriparatide dose in AU has been constrained , impacting consumer access . First sales figures suggest a moderate uptake, largely due to cost considerations and restricted https://nicolaswazf755122.mpeblog.com/75888666/750mcg-teriparatide-injection-access-sales-in-au